LATEST UPDATEVimal Elaichi Ad Controversy: Delhi High Court Reserves Verdict on Pleas Against Notices to Shah Rukh, Ajay, and Tiger
Vimarsh Naarad TV logoINDEPENDENT DIGITAL NEWSVimarsh–Naarad TVNEWS • VIEWS • PUBLIC VOICE
DIGITAL EDITIONYouTube
Browse sections

Vimal Elaichi Ad Controversy: Delhi High Court Reserves Verdict on Pleas Against Notices to Shah Rukh, Ajay, and Tiger

The Delhi High Court has reserved its verdict regarding the notices issued to Bollywood actors Shah Rukh Khan, Ajay Devgn, and Tiger Shroff by the Maharashtra FDA concerning Vimal Elaichi advertisements. The actors had challenged these notices in court. All eyes are now on the upcoming judicial order to determine the future course of this legal matter.

The legal dispute surrounding Vimal Elaichi advertisements has reached a critical stage at the Delhi High Court. The court has reserved its judgment on a petition challenging the notices issued by the Maharashtra Food and Drug Administration (FDA) to three prominent Bollywood stars. The actors involved in this ongoing controversy are Shah Rukh Khan, Ajay Devgn, and Tiger Shroff.

According to reports from Amar Ujala, the Maharashtra FDA had issued notices to these actors regarding their involvement in the promotional campaigns for the product. The actors subsequently approached the court to contest the validity of these notices, seeking legal intervention to address the regulatory concerns raised by the state authority.

During the proceedings, the court heard arguments from both the petitioners and the regulatory body. While the hearing has concluded, it remains unclear whether the actors have received any immediate relief from the court. Reserving the verdict indicates that the court will issue a formal order in the near future to resolve the dispute.

This controversy highlights the broader issue of celebrity endorsements and the strict adherence to advertising regulations. The Maharashtra FDA has frequently scrutinized various promotional campaigns, leading to the issuance of such notices to ensure compliance with state health and safety standards.

For the Bollywood stars, this case carries significant weight as it directly impacts their brand associations and legal responsibilities. Legal experts suggest that the court's final decision could set a precedent for how celebrity-led advertisements are handled in the future.

Currently, the film industry and the actors' fans are awaiting the court's final pronouncement. Once the order is delivered, it will become clear whether the actors are granted relief or if they must continue to engage with the legal process initiated by the FDA.

The court has not yet specified a date for the delivery of the verdict. Until the official order is released, the matter remains sub judice, and all involved parties are expected to abide by the judicial process.

SOURCES

Original references

01एंटरटेनमेंट डेस्क, अमर उजालाOpen original report ↗